Instrument Inactif

Autres langues Aquinox Pharmaceuticals Inc Nasdaq

Actions

Cours en clôture Nasdaq Autres places de cotation
-	-

18/06	Neurogene administre la dose élevée de NGN-401 à la première patiente de l'essai sur le syndrome de Rett	MT
18/06	Neurogene Inc. annonce la première patiente de la cohorte à haute dose de l'essai clinique de thérapie génique NGN-401 pour le syndrome de Rett	CI

Neurogene Announces Addition to Russell 3000 Index	02/07
Neurogene to Participate in BMO Genetic Medicines Summit	02/07
Neurogene Announces Addition to Russell 3000® Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Small Cap Comp Value Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Small Cap Completeness Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2000 Value Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Microcap Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 3000 Value Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2000 Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 3000E Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2500 Value Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Microcap Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2500 Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Small Cap Comp Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 3000E Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 3000 Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2000 Growth Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 2000 Dynamic Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell Microcap Value Index	01/07
Neurogene Inc.(NasdaqGM:NGNE) added to Russell 3000E Value Index	01/07

Aucun résultat pour cette recherche